Funding and collaborations

Funding Details

Deutsche Forschungsgemeinschaft/ Germany (DFG PA930/12); Wirtschaftsministerium Sachen-Anhalt (EFRE, ZS/2016/05/78617) and the Leibniz Association (Leibniz-Wettbewerb SAW-2015-IPB-2); Latvian Council of Science/ Latvia (lzp-2018/1-0275); Nasjonalforeningen (16154), HelseSØ/ Norway (2016062, 2019054, 2019055); Norsk forskningsrådet/ Norway (251290 FRIMEDIO, 260786 PROP-AD); Horizon 2020/ European Union (643417 (PROP-AD)).

PROP-AD is an EU Joint Programme - Neurodegenerative Disease Research (JPND) project. The project is supported through the following funding organisations under the aegis of JPND - (AKA #301228 – Finland , BMBF #01ED1605- Germany, CSO-MOH #30000-12631 - Israel, NFR #260786 - Norway, SRC #2015-06795 - Sweden). This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement #643417 (JPco-fuND).

International Collaborations:

Page visits: 1350